Lexaria signs agreement with unnamed pharmaceutical company to evaluate drug delivery technology
LEXX•Lexaria Bioscience entered an agreement with an unnamed pharmaceutical company to evaluate its DehydraTECH drug-delivery technology using one or more proprietary molecules. The agreement is its third pharmaceutical company relationship, separate from two existing material transfer agreements.
1. Technology evaluation agreement
Lexaria Bioscience entered an agreement with an unnamed pharmaceutical company to evaluate its DehydraTECH drug-delivery technology using one or more proprietary molecules. The company said this is its third pharmaceutical company relationship, separate from two existing material transfer agreements.
